Los Angeles Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $512K | Sell |
2,280
-140,294
| -98% | -$35M | ﹤0.01% | 869 |
|
|
2025
Q4 | $36M | Sell |
142,574
-242,214
| -63% | -$61.9M | 0.12% | 127 |
|
|
2025
Q3 | $105M | Sell |
384,788
-288,065
| -43% | -$78.7M | 0.36% | 55 |
|
|
2025
Q2 | $174M | Sell |
672,853
-100,306
| -13% | -$23.9M | 0.65% | 29 |
|
|
2025
Q1 | $173M | Buy |
773,159
+104,251
| +16% | +$24.3M | 0.77% | 27 |
|
|
2024
Q4 | $153M | Buy |
668,908
+250,746
| +60% | +$60.4M | 0.62% | 34 |
|
|
2024
Q3 | $102M | Sell |
418,162
-322,064
| -44% | -$72M | 0.41% | 57 |
|
|
2024
Q2 | $142M | Buy |
740,226
+241,195
| +48% | +$48.9M | 0.51% | 41 |
|
|
2024
Q1 | $98.8M | Buy |
499,031
+485,540
| +3,599% | +$89M | 0.34% | 66 |
|
|
2023
Q4 | $2.32M | Buy |
13,491
+11,685
| +647% | +$1.8M | 0.01% | 449 |
|
|
2023
Q3 | $267K | Sell |
1,806
-68,470
| -97% | -$12.4M | ﹤0.01% | 991 |
|
|
2023
Q2 | $15.4M | Buy |
+70,276
| New | +$15.7M | 0.06% | 223 |
|
|
2022
Q2 | – | Sell |
-15,724
| Closed | -$3.81M | – | 1439 |
|
|
2022
Q1 | $3.81M | Sell |
15,724
-161,936
| -91% | -$39.2M | 0.02% | 404 |
|
|
2021
Q4 | $46.3M | Buy |
177,660
+47,718
| +37% | +$12.4M | 0.17% | 120 |
|
|
2021
Q3 | $34.2M | Buy |
129,942
+60,911
| +88% | +$16.7M | 0.16% | 128 |
|
|
2021
Q2 | $17M | Sell |
69,031
-334,177
| -83% | -$70.3M | 0.08% | 222 |
|
|
2021
Q1 | $78.2M | Buy |
403,208
+80,742
| +25% | +$16.2M | 0.35% | 65 |
|
|
2020
Q4 | $68.5M | Sell |
322,466
-10,705
| -3% | -$2.13M | 0.29% | 76 |
|
|
2020
Q3 | $57.1M | Buy |
333,171
+26,201
| +9% | +$4.84M | 0.26% | 90 |
|
|
2020
Q2 | $58.9M | Buy |
306,970
+255,392
| +495% | +$41.8M | 0.28% | 85 |
|
|
2020
Q1 | $7.6M | Sell |
51,578
-1,353
| -3% | -$216K | 0.05% | 275 |
|
|
2019
Q4 | $8.2M | Buy |
52,931
+3,799
| +8% | +$548K | 0.04% | 312 |
|
|
2019
Q3 | $6.64M | Sell |
49,132
-403,770
| -89% | -$52.9M | 0.04% | 358 |
|
|
2019
Q2 | $55.3M | Sell |
452,902
-5,680
| -1% | -$629K | 0.3% | 84 |
|
|
2019
Q1 | $47.7M | Sell |
458,582
-6,700
| -1% | -$692K | 0.27% | 92 |
|
|
2018
Q4 | $53M | Buy |
465,282
+10,527
| +2% | +$1.13M | 0.33% | 76 |
|
|
2018
Q3 | $52.5M | Buy |
454,755
+9,495
| +2% | +$1.04M | 0.27% | 94 |
|
|
2018
Q2 | $46.1M | Buy |
445,260
+407,590
| +1,082% | +$41.2M | 0.26% | 98 |
|
|
2018
Q1 | $3.71M | Buy |
+37,670
| New | +$3.56M | 0.02% | 490 |
|
|
2016
Q4 | – | Sell |
-9,790
| Closed | -$634K | – | 1227 |
|
|
2016
Q3 | $634K | Hold |
9,790
| – | – | 0.01% | 833 |
|
|
2016
Q2 | $619K | Buy |
+9,790
| New | +$577K | 0.01% | 842 |
|
|
2013
Q4 | – | Sell |
-17,175
| Closed | -$907K | – | 1320 |
|
|
2013
Q3 | $907K | Buy |
17,175
+145
| +0.9% | +$7.03K | 0.01% | 703 |
|
|
2013
Q2 | $769K | Buy |
+17,030
| New | +$808K | 0.01% | 747 |
|
Other funds holding RMD
VCM
VPM
DAM
Los Angeles Capital Management's RMD Position: Q1 2026 in Review
Los Angeles Capital Management reduced its ResMed (RMD) stake by 98% in Q1 2026, selling an estimated $35M and leaving 2,280 shares worth $512K. The position accounts for ﹤0.01% of the portfolio, ranked #869.
Los Angeles Capital Management first reported a position in RMD in Q2 2013 and has held it in 33 quarters since. The position peaked at $174M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Los Angeles Capital Management held 2,280 shares of ResMed worth $512K as of Q1 2026.
- Los Angeles Capital Management sold 140,294 ResMed shares in Q1 2026, an estimated $35M.
- ResMed made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #869 holding.
- Los Angeles Capital Management first reported a position in ResMed in Q2 2013 and has held it in 33 quarters since.
- Los Angeles Capital Management's ResMed position peaked at $174M in Q2 2025.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.